語系:
繁體中文
English
說明(常見問題)
登入
回首頁
切換:
標籤
|
MARC模式
|
ISBD
Endocannabinoids
~
SpringerLink (Online service)
Endocannabinoids
紀錄類型:
書目-語言資料,印刷品 : Monograph/item
正題名/作者:
Endocannabinoids/ edited by Roger G. Pertwee.
其他作者:
Pertwee, Roger G.
出版者:
Cham :Imprint: Springer, : 2015.,
面頁冊數:
xii, 475 p. :ill., digital ; : 24 cm.;
Contained By:
Springer eBooks
標題:
Cytokines and Growth Factors. -
電子資源:
http://dx.doi.org/10.1007/978-3-319-20825-1
ISBN:
9783319208251
Endocannabinoids
Endocannabinoids
[electronic resource] /edited by Roger G. Pertwee. - Cham :Imprint: Springer,2015. - xii, 475 p. :ill., digital ;24 cm. - Handbook of experimental pharmacology,v.2310171-2004 ;. - Handbook of experimental pharmacology ;v.212..
There is currently considerable interest in the development of medicines that would enhance endocannabinoid-induced "autoprotection", for example through inhibition of endocannabinoid metabolizing enzymes or cellular uptake processes or that would oppose endocannabinoid-induced "autoimpairment". This volume describes the physiology, pathophysiology and pharmacology of the endocannabinoid system and potential strategies for targeting this system in the clinic.
ISBN: 9783319208251
Standard No.: 10.1007/978-3-319-20825-1doiSubjects--Topical Terms:
787581
Cytokines and Growth Factors.
LC Class. No.: QP801.C27
Dewey Class. No.: 615.7827
Endocannabinoids
LDR
:01433nam a2200313 a 4500
001
838019
003
DE-He213
005
20160407132232.0
006
m d
007
cr nn 008maaau
008
160616s2015 gw s 0 eng d
020
$a
9783319208251
$q
(electronic bk.)
020
$a
9783319208244
$q
(paper)
024
7
$a
10.1007/978-3-319-20825-1
$2
doi
035
$a
978-3-319-20825-1
040
$a
GP
$c
GP
041
0
$a
eng
050
4
$a
QP801.C27
072
7
$a
MMG
$2
bicssc
072
7
$a
MED071000
$2
bisacsh
082
0 4
$a
615.7827
$2
23
090
$a
QP801.C27
$b
E56 2015
245
0 0
$a
Endocannabinoids
$h
[electronic resource] /
$c
edited by Roger G. Pertwee.
260
$a
Cham :
$c
2015.
$b
Imprint: Springer,
$b
Springer International Publishing :
300
$a
xii, 475 p. :
$b
ill., digital ;
$c
24 cm.
490
1
$a
Handbook of experimental pharmacology,
$x
0171-2004 ;
$v
v.231
520
$a
There is currently considerable interest in the development of medicines that would enhance endocannabinoid-induced "autoprotection", for example through inhibition of endocannabinoid metabolizing enzymes or cellular uptake processes or that would oppose endocannabinoid-induced "autoimpairment". This volume describes the physiology, pathophysiology and pharmacology of the endocannabinoid system and potential strategies for targeting this system in the clinic.
650
2 4
$a
Cytokines and Growth Factors.
$3
787581
650
2 4
$a
Immunology.
$3
592892
650
2 4
$a
Psychopharmacology.
$3
644799
650
2 4
$a
Neurosciences.
$3
593561
650
2 4
$a
Cell Biology.
$3
593889
650
2 4
$a
Pharmacology/Toxicology.
$3
593882
650
1 4
$a
Biomedicine.
$3
593880
650
0
$a
Pharmacology, Experimental.
$3
676921
650
0
$a
Cannabinoids
$x
Physiological effect.
$3
583584
700
1
$a
Pertwee, Roger G.
$3
668962
710
2
$a
SpringerLink (Online service)
$3
593884
773
0
$t
Springer eBooks
830
0
$a
Handbook of experimental pharmacology ;
$v
v.212.
$3
882814
856
4 0
$u
http://dx.doi.org/10.1007/978-3-319-20825-1
950
$a
Biomedical and Life Sciences (Springer-11642)
筆 0 讀者評論
多媒體
評論
新增評論
分享你的心得
Export
取書館別
處理中
...
變更密碼[密碼必須為2種組合(英文和數字)及長度為10碼以上]
登入